AmpSeq: Detailed Company Information & Corporate Profile

Summary

AmpSeq is a biotech company headquartered in Gaithersburg, Maryland, founded in 2023. The firm focuses on advanced next-generation sequencing solutions for DNA, RNA, and gene expression analysis within genetics and genomics research.

With a lean team of 1-10 employees, AmpSeq generates revenues between $1 million and $10 million. Its specialty areas include NGS, DNA sequencing, RNA sequencing, and sequencing technologies that empower precision studies in biotechnology.

Leadership includes Chief Executive Officer Feng Qian, Senior Scientist Xiguang Xu, Bioinformatics Analyst Libin Huang, and others such as Everett Pustell (NGS Associate), Sheng Ding (Senior Director of R&D), Ruby Huang (Training & Development Lead), Benjamin Chimukangara (Single‑Cell Biology Scientist), Michelle (Business Development Director), Kiran Adhikari (Bioinformatics Scientist), and Luyi Yang (Marketing Intern).

AmpSeq’s team collaborates to deliver customized sequencing solutions, integrating cutting‑edge analytics with robust platform expertise for biomedicine innovation.